Dr Agarwals Healthcare IPO GMP Updates: Check Key Details Here

Posted by : sachet | Mon Jan 27 2025

Dr Agarwals Healthcare IPO GMP Updates: Check Key Details Here

Dr Agarwals Healthcare IPO will open for bidding on 29th January 2025 and close on 31st January 2025. It is the book-built issue comprised of a fresh issue of 754,62,686 shares and an offer for sale of 6,78,42,284 shares. 

The price band for Dr Agarwals Healthcare IPO is set between ₹382 to ₹402 per share. Investors can bid for a minimum lot of 35 shares worth ₹14,070. 

Dr Agarwals Healthcare IPO Details

IPO Open Date29th January 2025
IPO Close Date31st January 2025
IPO Allotment Date3rd February 2025
Refund Date4th February 2025
Face Value₹1 per share
Lot Size35 Shares
Issue Size7,53,04,970 shares (worth ₹3,027.26 crore)
Price Band₹382 to ₹ 402 per share
Issue TypeBook Built IPO
Listing AtBSE & NSE
Listing Date5th February 2025

Explanation

Dr Agarwals Healthcare IPO price: The company has declared a price band of ₹382 to ₹402. With this IPO, the company allows retail investors to make a bid for a minimum of one lot of 35 shares worth ₹14,070. The face value of Dr Agarwals Healthcare share is ₹1 per share. The shares of Dr Agarwals Healthcare, an eye care service provider, will be listed on BSE & NSE on its tentative listing day, 5th February 2025. Scroll down to check Dr Agarwals Healthcare IPO GMP and reviews. 

Dr Agarwals Healthcare IPO GMP Grey Market Premium

As of 27th January 2025 (9:14:20 AM), Dr Agarwals Healthcare IPO GMP stands at ₹32 per share. Thus, the estimated listing price would be ₹434 (32+402). This indicates that the estimated listing gain in this IPO could be 7.96%. However, GMP details are subject to change on the basis of market conditions and fluctuations. Explore the table below to learn about Dr Agarwals Healthcare IPO GMP updates in the past 4 days. 

GMP DateGMPEstimated Listing Price (in ₹)Estimated Listing Gain (in %)
27-01-2025₹32₹4347.96%
26-01-2025₹32₹4347.96%
25-01-2025₹30₹4327.46%
24-01-2025₹54₹45613.43%

*Data is updated as of 27th January 2025.   

Objectives of Dr Agarwals Healthcare IPO

Dr Agarwals Healthcare Limited proposed to utilise the proceeds from the fresh issue of the IPO in the following objectives. 

  • Repayment of borrowings. 
  • General corporate purposes. 
  • Unidentified inorganic acquisitions.

Dr Agarwals Healthcare IPO Registrar 

Dr Agarwals Healthcare IPO is set to open on 29th January 2025 to raise ₹3,027.26 crore. Kfin Technologies Limited is the registrar of this IPO and is awaiting to manage allotment and refund procedures. Moreover, the book-running lead managers of this IPO are mentioned below:

  • Kotak Mahindra Capital Company Ltd. 
  • Morgan Stanley India Company Pvt. Ltd. 
  • Jefferies India Pvt. Ltd.
  • Motilal Oswal Investment Advisors Ltd. 

Dr Agarwals Healthcare IPO Review

Dr Agarwsls Healthcare IPO has gained a positive rating from industry experts, brokers, and institutional investors. As of 31st March 2024, the company reported a 33.44% increase in revenue and a 113.06% rise in its net worth. However, a slight decrease of 7.9% in profit after tax of Dr Agarwals Healthcare Limited might be a point of concern. 

50% of analysts recommended applying for this IPO to earn profit in the Indian share market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Till then, you can explore the technical analysis and peer comparison of the company to know whether you should apply for this IPO or not.

Also Read: Dr Agarwals Healthcare IPO Review: Apply or Avoid?

Dr Agarwals Healthcare IPO Technical Analysis

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 130.44
PB Ratio (Price-to-Book)7.96
EPS (Earnings Per Share)3.08
ROE (Return on Equity)9.33%
Debt-to-Equity Ratio0.70
RoCE 14.61%
PAT Margin (Profit After Tax)6.90
Market Capitalisation₹12,698.37 crore

*Data is updated as of 27th January 2025.

The PE ratio of Dr Agarwals Healthcare IPO is valued at 130.44. Moreover, it is the pre-issue PE ratio. The post-issue PE ratio would be 160.48. 

Dr Agarwals Healthcare IPO Peer Comparison

Company NameRevenue (in cr.)PE RatioFace Value (in ₹)EPS (in ₹)RoNW (in %)NAV (in ₹)
Dr Agarwals Healthcare Limited1,376.45130.4413.086.21%50.53
Jupiter Life Line Hospitals Limited940.2653.761028.2215.77%191.93
Max Healthcare Institute Limited1,420.0094.801010.898.49%90.51
Global Health Limited825.5355.99214.1612.14%113.50
Fortis Healthcare Limited1,790.4268.71108.691.37%103.94
Apollo Hospitals Enterprise Limited4,940.7081.54582.2815.67%521.15
Krishna Institute of Medical Sciences Limited633.8071.2228.2823.30%50.03
Rainbow Children’s Medicare Limited341.1060.161022.8017.23%132.29
Healthcare Global Limited1,087.90122.30104.094.21%61.82
Narayana Hrudayalaya Limited1,280.0033.581038.1127.29%156.86
Aster DM Healthcare Limited973.594.4210108.053.58%60.41

*Data is updated as of 27th January 2025.

Explore Previous or Current IPOs

H.M. Electro Mech IPO Review: Apply or Avoid?

Denta Water and Infra IPO 2025 Live Updates and Reviews

Stallion India IPO 2025: Check Live GMP Details and Investment Insights

Laxmi Dental IPO Today: Know Day 2 GMP, Subscription Status, and Other Key Details 

Indo Farm Equipment Share Listing: What Investors Need to Know? 

Transrail Lighting IPO: Fundamental Analysis

FAQs on Dr Agarwals Healthcare IPO 

1. How is Dr Agarwals Healthcare IPO?

Ans. Dr Agarwals Healthcare IPO GMP (Grey Market Premium) stands at ₹32 (7.96% up) on 27th January 2025. It indicates that the estimated listing price could be ₹434. It is the book-built issue of 7,53,04,970 shares worth ₹3,027.26 crore, and the face value of each share is ₹1. 

2. Is Dr Agarwals Healthcare IPO good?

Ans. Dr Agarwals Healthcare IPO has gained a positive rating from industry experts, brokers and institutional investors. The company has an effective presence in India in over 117 metro and non-metro cities. Moreover, consistent growth in the financial position of Dr Agarwals Healthcare Limited indicates that stocks could show an upside movement in the long-term. 

3. What is the price of Dr Agarwals Healthcare IPO?

Ans. Dr Agarwals Healthcare IPO price band has been set between ₹398 to ₹402 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 35 shares worth ₹14,070. Moreover, NIIs are required to bid for a minimum of 15 lots (525 shares) worth ₹2,11,050.

4. Who is the registrar of Dr Agarwals Healthcare IPO?

Ans. Kfin Technologies Limited is the registrar of this IPO and is awaiting management of the IPO allotment and refund initiation process. For any query on Dr Agarwals Healthcare IPO allotment and refund, reach out to reachus@kfintech.com or 04067162222 / 04079611000.

Disclaimer: The above information is accumulated from authentic sources and is just for informational purposes. To have detailed information about Dr Agarwal Healthcare IPO, download the Dr Agarwal Healthcare IPO RHP and Dr Agarwal Healthcare IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
arrow down